These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7453954)

  • 1. MMPI prediction of imipramine response: a replication study.
    Ramsey TA; Strand S; Stern S; Mendels J
    Neuropsychobiology; 1981; 7(2):94-8. PubMed ID: 7453954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of antidepressant responses to imipramine.
    Donnelly EF; Murphy DL; Waldman IN; Goodwin FK
    Neuropsychobiology; 1979; 5(2):94-101. PubMed ID: 431801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE; Biggs J; Jacobs M; Holden K
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.
    Sotsky SM; Glass DR; Shea MT; Pilkonis PA; Collins JF; Elkin I; Watkins JT; Imber SD; Leber WR; Moyer J
    Am J Psychiatry; 1991 Aug; 148(8):997-1008. PubMed ID: 1853989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
    Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine blood levels and clinical outcome.
    Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minnesota Multiphasic Personality Inventory correlates of panic disorder with agoraphobia: changes with treatment.
    Ito LM; Gorenstein C; Gentil V; Miyakawa E
    Braz J Med Biol Res; 1995 Sep; 28(9):961-5. PubMed ID: 8580883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramine.
    Strober M; Freeman R; Rigali J
    Psychopharmacol Bull; 1990; 26(1):80-4. PubMed ID: 2196630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an MMPI scale to predict antidepressant response to lithium.
    Garvey MJ; Johnson RA; Valentine RH; Schuster V
    Psychiatry Res; 1983 Sep; 10(1):17-20. PubMed ID: 6580655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of chronic depression treated with imipramine.
    Kocsis JH; Sutton BM; Frances AJ
    J Clin Psychiatry; 1991 Feb; 52(2):56-9. PubMed ID: 1993636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Harrison W; Wagner G
    Am J Psychiatry; 1994 Apr; 151(4):516-23. PubMed ID: 7908501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with imipramine and mianserin. A controlled pilot study.
    Lauritzen L; Clemmesen L; Klysner R; Loldrup D; Lunde M; Schaumburg E; Waarst S; Bech P
    Pharmacopsychiatry; 1992 Jul; 25(4):182-6. PubMed ID: 1528957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.